Theralase Technologies Inc. TLTFF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 10.16% | 16.58% | 5.52% | 2.51% | 6.06% |
| Total Depreciation and Amortization | -4.60% | -2.89% | -4.28% | -7.65% | -8.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -35.60% | -6.82% | 10.76% | 32.60% | 11.67% |
| Change in Net Operating Assets | -324.36% | -126.11% | -142.34% | 242.49% | -54.34% |
| Cash from Operations | -4.98% | -21.26% | 3.84% | 39.75% | 5.48% |
| Capital Expenditure | 123.64% | 118.31% | -133.79% | -283.33% | -224.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 127.84% | 120.95% | -133.79% | -283.33% | -224.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 4.34% | -8.24% | -7.85% | 8.21% | 11.81% |
| Issuance of Common Stock | 173.23% | 34.08% | -19.35% | -44.81% | -13.30% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 0.00% | 0.00% | -- | -- |
| Cash from Financing | 192.22% | 48.32% | -11.38% | -44.85% | -15.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,480.78% | 3,427.78% | -135.59% | -355.46% | -2,234.38% |